(Q40238236)

18 September 2017

Mutational landscape of B-cell post-transplant lymphoproliferative disorders (English)

1 reference

18 September 2017

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28419429%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Darius Juskevicius

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28419429%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Kikkeri N Naresh

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28419429%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

5

Stephan Dirnhofer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28419429%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

1

Thomas Menter

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28419429%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

author name string

Mary Alikian

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28419429%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Juerg Steiger

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28419429%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

language of work or name

English

0 references

publication date

17 April 2017

1 reference

British Journal of Haematology

18 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28419429%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

volume

178

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28419429%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28419429%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

page(s)

48-56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28419429%20AND%20SRC:MED&resulttype=core&format=json

Combined genetic inactivation of β2-Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma

6 June 2020

cites work

1 reference

EBV-negative monomorphic B-cell post-transplant lymphoproliferative disorders are pathologically distinct from EBV-positive cases and frequently contain TP53 mutations.

21 January 2018

1 reference

Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

21 January 2018

1 reference

Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies

21 January 2018

1 reference

Next-Generation Sequencing in Diffuse Large B-Cell Lymphoma Highlights Molecular Divergence and Therapeutic Opportunities: a LYSA Study.

21 January 2018

1 reference

EBV-Positive and EBV-Negative Posttransplant Diffuse Large B Cell Lymphomas Have Distinct Genomic and Transcriptomic Features

21 January 2018

1 reference

COSMIC: exploring the world's knowledge of somatic mutations in human cancer

21 January 2018

1 reference

Prevalence of targetable oncogenic mutations and genomic alterations in Epstein-Barr virus-associated diffuse large B-cell lymphoma of the elderly

21 January 2018

1 reference

Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma

21 January 2018

1 reference

Molecular epidemiology of EBNA-1 substrains of Epstein-Barr virus in posttransplant lymphoproliferative disorders which have infrequent p53 mutations

21 January 2018

1 reference

EBV LMP2A affects LMP1-mediated NF-kappaB signaling and survival of lymphoma cells by regulating TRAF2 expression

21 January 2018

1 reference

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

21 January 2018

1 reference

Distinct genetic evolution patterns of relapsing diffuse large B-cell lymphoma revealed by genome-wide copy number aberration and targeted sequencing analysis.

21 January 2018

1 reference

Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity?

21 January 2018

1 reference

dbNSFP v3.0: A One-Stop Database of Functional Predictions and Annotations for Human Nonsynonymous and Splice-Site SNVs

21 January 2018

1 reference

The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative Disorder

21 January 2018

1 reference

Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07).

21 January 2018

1 reference

EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations

21 January 2018

1 reference

Comprehensive phenotypic characterization of PTLD reveals potential reliance on EBV or NF-κB signalling instead of B-cell receptor signalling

21 January 2018

1 reference

Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma

21 January 2018

1 reference

Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity?

21 January 2018

1 reference

The genetic landscape of diffuse large B-cell lymphoma

21 January 2018

1 reference

Inactivating mutations of acetyltransferase genes in B-cell lymphoma

21 January 2018

1 reference

Regulation of MHC class I assembly and peptide binding

21 January 2018

1 reference

Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain

21 January 2018

1 reference

The 2016 revision of the World Health Organization classification of lymphoid neoplasms

21 January 2018

1 reference

Gene Mutation Profiles in Primary Diffuse Large B Cell Lymphoma of Central Nervous System: Next Generation Sequencing Analyses

21 January 2018

1 reference

Shaping the Molecular Landscape of Posttransplantation Lymphoproliferative Disorders.

21 January 2018

1 reference

Multiparameter analysis of homogeneously R-CHOP-treated diffuse large B cell lymphomas identifies CD5 and FOXP1 as relevant prognostic biomarkers: report of the prospective SAKK 38/07 study.

21 January 2018

1 reference

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

21 January 2018

1 reference

B-cell receptor signaling in diffuse large B-cell lymphoma

21 January 2018

1 reference

Characteristic Pattern of Chromosomal Imbalances in Posttransplantation Lymphoproliferative Disorders: Correlation with Histopathological Subcategories and EBV Status

21 January 2018

1 reference

Gene Expression Profiling Reveals Clear Differences Between EBV-Positive and EBV-Negative Posttransplant Lymphoproliferative Disorders

21 January 2018

1 reference

Single nucleotide polymorphism-arrays provide new insights in the pathogenesis of post-transplant diffuse large B-cell lymphoma

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/BJH.14633

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28419429%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

1 reference